CalciMedica is trading 5.39% down at $1.14 on October 13, 2026, with no company-specific announcement or catalyst identified. - The company’s press-release listing has no October 13 release, and its latest listed SEC filing predates the session. - XBI was down 2.01% during the regular session while broad U.S. indexes were nearly flat; sector weakness may be contributing, but it is not a confirmed explanation for CalciMedica’s larger decline. - The stock closed down 5.12% on October 12 and 12.16% on October 8.